UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 6)*

The Providence Service Corporation

(Name of Issuer)

Common Stock, Par Value $0.001 Per Share

(Title of Class of Securities)

743815102

(CUSIP Number)

Christopher Shackelton/Adam Gray

Metro Center

1 Station Place, 7th Floor South

Stamford, CT 06902

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

February 2, 2015

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 140.13d-1(g), check the following box.   ¨

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 743815102 (Common Stock)

Page 2 of 15

CUSIP No. 743815102 (Common Stock)

Page 3 of 15

CUSIP No. 743815102 (Common Stock)

Page 4 of 15

CUSIP No. 743815102 (Common Stock)

Page 5 of 15

CUSIP No. 743815102 (Common Stock)

Page 6 of 15

CUSIP No. 743815102 (Common Stock)

Page 7 of 15

CUSIP No. 743815102 (Common Stock)

(1) Includes 376,125 shares of Common Stock that could be obtained upon the conversion of 150,000 shares of the Issuer’s to be issued Series A Preferred Stock that the Reporting Persons may acquire pursuant to the Option. Also includes 1,544,420 shares of Common Stock that could be obtained upon the conversion shares of shares of Series A Preferred Stock beneficially owned by the Reporting Person.

Page 8 of 15

CUSIP No. 743815102 (Common Stock)

Explanatory Note: This Amendment No. 6 (this “Amendment”), to the Schedule 13D (the “Initial 13D”) filed by the Filers (as defined below in Item 2) with the U.S. Securities and Exchange Commission (the “Commission”) on July 30, 2012, as amended and supplemented by Amendment No. 1 to the Initial 13D filed on August 20, 2012, Amendment No. 2 to the Initial 13D filed on September 13, 2012, Amendment No. 3 to the Initial 13D filed on November 28, 2012, Amendment No. 4 to the Initial 13D filed on August 15, 2013 and Amendment No. 5 to the Initial 13D filed on October 28, 2014, amends and supplements the items set forth herein.

Item 1. Security and Issuer.

Item 1 is amended and restated in its entirety as follows.

The title of the class of equity securities to which this statement relates to is the Common Stock, $0.001 par value per share (the “Common Stock”) of The Providence Service Corporation, a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 64 East Broadway Blvd, Tucson, Arizona 85701.

Item 2. Identity and Background.

Item 1 is amended and restated in its entirety as follows.

The persons filing this statement and the persons enumerated in Instruction C of Schedule 13D and, where applicable, their respective places of organization, general partners, directors, executive officers and controlling persons, and the information regarding them, are as follows:

CCM is the investment adviser to CCP, CCP2 and CCC, which are investment limited partnerships. CC is the General Partner of CCP, CCP2 and CCC, and Gray and Shackelton are the managers of CC. Gray and Shackelton are the managers of CCM.

Page 9 of 15

CUSIP No. 743815102 (Common Stock)

Item 3. Source and Amount of Funds or Other Consideration.

Item 3 is supplemented as follows:

The source and amount of funds used in purchasing the Series A Preferred Stock pursuant to the Rights Offering and the Standby Purchase Agreement (as those terms are defined in Item 4 below) were as follows: [Coliseum to confirm.]

Item 4. Purpose of Transaction.

Item 4 is amended and restated in its entirety as follows:

Shackelton is a director of the Issuer and was appointed as Chairman of the Board of Directors of the Issuer effective

November 19, 2012.

On October 23, 2014, the Issuer issued to a separate account managed by CCM (the “Separate Account”), CCP, CCP2, and CCC (collectively, the “Investors”) a 14.0% Unsecured Subordinated Note in aggregate principal amount of $65.5 million (the “Note”). The Note had a maturity date of September 30, 2018 and accrued interest at a rate of 14.0% per annum, subject to additional penalty interest up to an aggregate of 18.5% per annum. Interest from the issuance date to, but excluding, the 120th day after the issuance date, was paid in cash in the amount of $3,014,795 on the issuance of the Note. Thereafter interest was payable by increasing the principal amount of the Note as pay-in-kind interest and was paid quarterly, in arrears. The Issuer used the proceeds from the issuance of the Note to finance, in part, the Issuer’s October 23, 2014 acquisition (the “Matrix Acquisition”) of CCHN Group Holdings, Inc., the parent company of Community Care Health Network, Inc. (dba Matrix Medical Group), pursuant to an Agreement and Plan of Merger, dated as of September 17, 2014. Upon consummation of the Rights Offering and the issuance of Series A Preferred Stock on February 11, 2015, the Note was paid off with the net proceeds received from the Rights Offering.

The foregoing description of the Note is qualified in its entirety by reference to the Note, which is listed as Exhibit 2 to this Amendment and is incorporated herein by reference.

On February 11, 2015, the Issuer completed a registered Rights Offering (the “Rights Offering”), pursuant to which all holders of Common Stock at 5:00 p.m. on January 5, 2015 received non-transferrable subscription rights to purchase their pro rata share of $65.5 million of Series A Preferred Stock at a price of $100.00 per share of Series A Preferred Stock (the “Subscription Price”). The Investors acquired 91,800 shares of Series A Preferred Stock pursuant to their rights as stockholders in the Rights Offering. In connection with the Rights Offering, on October 23, 2014 the Issuer entered into a standby purchase agreement (the “Standby Purchase Agreement”) with the Investors, pursuant to which, among other things, the Investors agreed to purchase, substantially simultaneously with the completion of the Rights Offering, in the aggregate, all of the available Series A Preferred Stock not otherwise sold in the Rights Offering following the exercise of the subscription privileges of holders of Common Stock. As part of the transaction, on October 23, 2014 the Issuer paid the Investors a fee of $2,947,000. In addition, the Investors were granted the Option, which is exercisable within 30 days following the completion of the Rights Offering, to purchase additional Series A Preferred Stock with a value based on the Subscription Price of $100 at a price per share equal to 105% of the Subscription Price (For the avoidance of doubt, if the Option is exercised in full, the Investors would pay an aggregate price of $15.75 million and receive 150,000 shares of Series A Preferred Stock). Pursuant to the Standby Purchase Agreement, the Investors purchased 524,116 shares of Series A Preferred Stock on February 11, 2015.

Page 10 of 15

CUSIP No. 743815102 (Common Stock)

The foregoing description of the Standby Purchase Agreement is qualified in its entirety by reference to the Standby Purchase Agreement, which is listed as Exhibit 3 to this Amendment and is incorporated herein by reference.

In accordance with the certificate of designations for the Series A Preferred Stock, each share of Series A Preferred Stock is initially convertible into approximately 2.5075226 shares of common stock, which is equivalent to the initial liquidation preference of $100.00 (subject to adjustment upon the occurrence of certain events, including being increased in the event quarterly dividends are not paid) (the “Liquidation Preference”) divided by the initial conversion price of $39.88 per share (subject to adjustment upon the occurrence of certain events). If, upon conversion of the Series A Preferred Stock, a holder would be entitled to receive a fractional interest in a share of Common Stock, the Issuer will, upon conversion, pay cash in lieu of such fractional interest.

The 615,916 shares of Series A Preferred Stock purchased by the Investors pursuant to the Rights Offering and the Standby Purchase Agreement is, subject to certain conditions, convertible into approximately 1,544,420 shares of Common Stock. The rules of The Nasdaq Stock Market (“Nasdaq”) require stockholder approval in instances where the issuance of capital stock of the Company causes a change of control (as defined under Nasdaq’s rules), which generally is deemed to occur when a stockholder’s holding of the outstanding voting stock of a company increases to more than 20%. If the Series A Preferred Stock was freely convertible into Common Stock, the issuance of Series A Preferred Stock to the Investors pursuant to Rights Offering and the Standby Purchase Agreement would result in a change of control under Nasdaq’s rules. In order to avoid such change of control, until the Issuer’s stockholders vote to approve this change of control (“Stockholder Approval”), there are restrictions on how and when the Investors may vote and convert their shares Series A Preferred stock into Common Stock. In addition, prior to the stockholder meeting to seek the Stockholder Approval, none of the outstanding shares of Series A Preferred Stock will be convertible into shares of Common Stock. After such stockholder meeting any shares of Series A Preferred Stock (other than shares certain shares held by the Investors if Stockholder Approval is not obtained) may, at the option of the holder, be converted at any time into fully paid and nonassessable shares of Common Stock.

In particular, if Stockholder Approval is not obtained, then the Series A Preferred stock beneficially owned by the Investors and their respective affiliates may not be converted to the extent that after giving effect to such conversion, the Investors and their respective affiliates would beneficially own, in the aggregate, in excess of 19.99% of the shares of Common Stock outstanding immediately after giving effect to such conversion (the “Conversion Cap”). The Conversion Cap will no longer apply to the Series A Preferred Stock beneficially owned by the Investors upon the occurrence of certain events, including, for example, receipt of the Stockholder Approval.

Holders of shares of Series A Preferred Stock are entitled to vote with the holders of shares of Common Stock (and any other class or series that may similarly be entitled to vote with the holders of Common Stock) and not as a separate class, at any annual or special meeting of stockholders of the Issuer, and may act by written consent in the same manner as the holders of Common Stock, on an as-converted basis. However, prior to the receipt of the Stockholder Approval, the convertible preferred stock beneficially owned by the Investors may only be voted to the extent that the aggregate voting power of all of the Issuer’s voting stock that is beneficially owned by the Investors and their respective affiliates does not exceed 19.99% of the aggregate voting power of all of the Issuer’s voting stock outstanding on the applicable record date for determining stockholders who may vote with respect to any proposal (the “Voting Cap”). The Voting Cap will no longer apply to the Series A Preferred Stock beneficially owned by the Investors upon the occurrence of certain events, including, for example, receipt of Stockholder Approval.

Page 11 of 15

CUSIP No. 743815102 (Common Stock)

The Issuer may pay noncumulative cash dividends on each share of Series A Preferred Stock at a rate of 5.5% per annum on the Liquidation Preference then in effect (a “cash dividend”). In the event the Issuer does not declare and pay a cash dividend, the Liquidation Preference on the Series A Preferred stock will increase to an amount equal to the Liquidation Preference in effect at the start of the applicable dividend period, plus an amount equal to such then applicable Liquidation Preference multiplied 8.5% per annum (a “PIK dividend”).

Pursuant to an Exchange Agreement, dated February 11, 2015, between the Investors and the Issuer, if Stockholder Approval is not obtained by November 7, 2015, the shares of Series A Preferred Stock beneficially owned by the Investors that were acquired by them initially and directly (i) in the Rights Offering pursuant to the exercise of the relevant subscription rights, if any, (ii) pursuant to their respective obligations under the Standby Purchase Agreement to purchase unsubscribed shares, and (iii) if exercised, pursuant to the Option, will be exchanged automatically for shares of newly created Series A-1 convertible preferred stock (the “Series A-1 Preferred Stock”), which will be identical to the Series A Preferred Stock, except that the Series A-1 Preferred Stock will pay cash dividends at a rate of 10.5% per annum and PIK dividends at a rate of 13.5% per annum.

The foregoing description of the Exchange Agreement is qualified in its entirety by reference to the Note, which is listed as Exhibit 2 to this Amendment and is incorporated herein by reference.

The Filers acquired the Common Stock and Series A Preferred Stock for investment purposes, and such purposes were made in the Filers’ ordinary course of business. In pursuing such investment purposes, the Filers may further purchase, hold, vote, trade, dispose or otherwise deal in the Common Stock or the Series A Preferred Stock at times, and in such manner, as they deem advisable to benefit from changes in market prices of the Common Stock or the Series A Preferred Stock, changes in the Issuer’s operations, business strategy or prospects, or from a sale or merger of the Issuer. To evaluate such alternatives, the Filers routinely will monitor the Issuer’s operations, prospects, business development, management, competitive and strategic matters, capital structure, and prevailing market conditions, as well as alternative investment opportunities, liquidity requirements of the Filers and other investment considerations. Consistent with their investment research methods and evaluation criteria, the Filers may discuss such matters with management or directors of the Issuer, other shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other investors. Such factors and discussions may materially affect, and result in, the Filers’ modifying their ownership of the Common Stock and the Series A Preferred Stock, exchanging information with the Issuer pursuant to appropriate confidentiality or similar agreements, proposing changes in the Issuer’s operations, governance or capitalization, or in proposing one or more of the other actions described in paragraphs (a) through (j) of Item 4 of Schedule 13D. The Filers reserve the right to formulate other plans and/or make other proposals and take such actions with respect to their investment in the Issuer, including any or all of the actions set forth in paragraphs (a) through (j) of Item 4 of Schedule 13D, or acquire additional Common Stock or Series A Preferred Stock or dispose of all Common Stock or Series A Preferred Stock beneficially owned by them, in public market or privately negotiated transactions. The Filers may at any time reconsider and change their plans or proposals relating to the foregoing.

Item 5. Interest in Securities of the Issuer.

Item 5 is amended and supplemented as follows:

The information relating to the beneficial ownership of Common Stock by each of the Filers set forth in Rows 7 through 13 of the cover pages hereto is incorporated herein by reference. The percentages set forth in Row 13 for all cover pages filed herewith are calculated based upon 15,856,177 shares of Common Stock outstanding as of October 23, 2014, as reported in the Issuer’s prospectus relating to the Rights Offering filed with the SEC pursuant to Rule 424(b)(3) on January 6, 2015.

Page 12 of 15

CUSIP No. 743815102 (Common Stock)

The Filers have not effected any transactions in the Common Stock in the sixty days preceding the filing of this Amendment.

The information in Items 4 and 6 is incorporated herein by reference.

Item 6. Contracts, Arrangement, Understandings or Relationships with Respect to Securities of the Issuer.

CCM is an investment adviser whose clients, including CCP, CCP2, CCC and the Separate Account, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. CC is the general partner of CCP, CCP2 and CCC. Gray and Shackelton are the managers of CC and CCM. CCM may have the right to receive performance-related fees from the Separate Account, and CC may have the right to receive performance-related fees from CCP, CCP2 and CCC.

The information in Item 4 is incorporated herein by reference.

Item 7. Material to Be Filed as Exhibits.

Page 13 of 15

CUSIP No. 743815102 (Common Stock)

SIGNATURES

After reasonable inquiry and to the best of my knowledge, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 20, 2015

Page 14 of 15

CUSIP No. 743815102 (Common Stock)

EXHIBIT 1

Joint Filing Agreement Pursuant to Rule 13d-1

This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities and Exchange Act of 1934, as amended (the “Act”) by and among the parties listed below, each referenced to herein as a “Joint Filer.” The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1.

Date: February 20, 2015

Exhibit 4

SERIES A PREFERRED STOCK EXCHANGE AGREEMENT

This SERIES A PREFERRED STOCK EXCHANGE AGREEMENT (the “Agreement”), dated as of February 11, 2015, is made by and among Coliseum Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners II, L.P., a Delaware limited partnership, Coliseum Capital Co-Invest, L.P., a Delaware limited liability company, and Blackwell Partners, LLC, a Georgia limited liability company (each, an “Investor”, and collectively, the “Investors”), and The Providence Service Corporation, a Delaware corporation (the “Company”).

RECITALS

A. The Company and the Investors are party to that certain Standby Purchase Agreement, dated as of October 23, 2014 (the “Standby Purchase Agreement”), pursuant to which, among other things, the Company has agreed to sell shares of Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”) pursuant to a registered rights offering (the “Rights Offering”), and the Investors have agreed to purchase any Series A Preferred Stock that are not sold in the rights offering.

B. The Standby Purchase Agreement provides for this Agreement to be executed and delivered by the Company and the Investors in order to provide that shares of the Series A Preferred Stock Beneficially Owned by the Investors and acquired by them initially and directly (i) in the Rights Offering pursuant to the exercise of the relevant subscription rights, if any, (ii) pursuant to their respective obligations under Standby Purchase Agreement to purchase Unsubscribed Shares in the respective Commitment Amounts as defined and provided therein, and (iii) pursuant to the option in respect of Additional Shares as defined and provided therein (collectively, the “Exchangeable Shares”), may be exchanged for shares of the Company’s Series A-1 Convertible Preferred Stock, par value $0.001 per share (the “Series A-1 Preferred Stock”), in accordance with the terms and provisions hereof. Except with respect to shares of Series A Preferred Stock defined as “Exchangeable Shares” herein, no other shares of Series Preferred Stock shall be entitled to the exchange rights set forth herein.

C. In the event the Stockholder Approval (as defined in the Certificate of Designations of Series A Convertible Preferred Stock of the Company (the “Series A Designation”)) has not been obtained by November 7, 2015 (the “Stockholder Vote Deadline”), each Investor wishes to exchange such Investor’s Exchangeable Shares for shares of Series A-1 Preferred Stock, on the terms and conditions set forth herein.

D. The Company and the Investors are executing and delivering this Agreement in reliance on the exemption from securities registration afforded by the provisions of Section 3(a)(9) of the Securities Act of 1933, as amended.

AGREEMENT

NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Investors hereby agree as follows:

(a) Exchange of Exchangeable Shares for Series A-1 Preferred Stock. The Company and the Investors hereby agree that if the Stockholder Approval has not been obtained by the Stockholder Vote Deadline, then on and as of the date immediately following the Stockholder Vote Deadline, all of the Exchangeable Shares automatically (without further action) will be exchanged for that number of shares of Series A-1 Preferred Stock equal to the quotient obtained by dividing (i) the aggregate Liquidation Preference (as defined in the Series A Designation) then in effect with respect to the aggregate number of Exchangeable Shares to be exchanged, by (ii) $100 (such shares of Series A-1 Preferred Stock obtained in the exchange, the “Acquired Securities”), plus cash in lieu of fractional shares, as set out in Section 1(b).

(b) Fractional Shares. No fractional shares of Series A-1 Preferred Stock will be delivered to the Investors upon exchange. In lieu of fractional shares otherwise issuable, the Investors will be entitled to receive an amount in cash equal to the fraction of a share of Series A-1 Preferred Stock, multiplied by $100. The determination as to whether the number of shares of Series A-1 Preferred Stock to be delivered to an Investor upon the exchange of such Investor’s Exchangeable Shares will include a fractional share (in lieu of which cash would be paid hereunder) shall be based on the aggregate number of Exchangeable Shares of such Investor that are being exchanged pursuant to Section 1(a).

(c) Exchange of Certificates. At the Closing (as defined below), (i) the Company shall deliver to each Investor, and each Investor shall receive from the Company on the Closing Date (as defined below), one or more certificates representing the number of shares of Acquired Securities issuable to such Investor pursuant to Section 1(a), in each case duly executed on behalf of the Company and registered in the name of such Investor, and (ii) each Investor shall (A) deliver to the Company, and the Company shall receive from each Investor on the Closing Date, certificates representing the applicable Exchangeable Share with respect to such Investor (the “Certificates”), in each case duly endorsed for transfer and/or accompanied by a duly executed stock transfer power to the Company in the form attached as Exhibit A or (B) transfer to the Company all remaining interests in any Exchangeable Shares with respect to such Investor in book-entry form in compliance with the Depositary Trust Company’s procedures with respect thereto (such deliveries to the Company by the Investors, collectively, the “Exchange”). Effective as of the effective date of the exchange contemplated by Section 1(a), all of the Exchangeable Shares shall be deemed cancelled and each Investor forever forfeits and waives all rights to and claims under the Exchangeable Shares delivered to the Company in the Exchange, and to the extent not delivered to the Company, the Certificates or book-entry interests, as the case may be, shall represent only the right to receive new shares representing the Acquired Shares. Each Investor hereby authorizes and directs the Company to marked “cancelled” on the Certificates effective as of the Closing.

(d) Closing. The closing (the “Closing”) of the Exchange shall occur at the offices of Paul Hastings LLP, 75 East 55th Street, New York, NY 10022. The date and time of the Closing (the “Closing Date”) shall be 9:30 a.m., New York time, on the fifth (5th) Business Day immediately following the Stockholder Vote Deadline. As used herein “Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to remain closed.

2

(a) Each Investor, severally and not jointly, represents and warrants to the Company that as of the effective date of the exchange contemplated by Section 1(a) and on the Closing Date such Investor will be the record and Beneficial Owner of all of the Exchangeable Shares to be exchanged by such Investor pursuant to this Agreement, free and clear of any preemptive rights and any direct or indirect charge, pledge, option, mortgage, deed of trust, hypothecation, security interest, royalty or similar right, warrant, purchase right, lease, license or other encumbrance (other than restrictions pursuant to applicable law) (collectively, “Liens”). Upon consummation of the transactions contemplated by this Agreement, the Company will obtain good and valid title to the Exchangeable Shares exchanged by such Investor pursuant to this Agreement and such Exchangeable Shares shall be free and clear of any Liens (other than any Liens imposed upon the Series A Preferred Stock by the Company).

(b) The Company represents and warrants to the Investors that the issuance of the Acquired Securities will be, as of the Closing, duly authorized and upon issuance in accordance with the terms of this Agreement such Acquired Securities shall be validly issued, fully paid and non-assessable.

(c) The Company and each of the Investors acknowledge that no commission or other remuneration has been paid or given directly or indirectly for soliciting the Exchange.

(a) Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware.

(b) Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

(c) Entire Agreement; Amendments. This Agreement and the Standby Purchase Agreement and the schedules and exhibits attached hereto and thereto constitute the entire understanding among the Investors and the Company, and supersede all prior agreements and understandings related to the subject matter hereof. This Agreement may be modified or amended only with the written consent of the Company and the Investors.

(d) Notices. All notices, communications and deliveries required or permitted by this Agreement shall be made in accordance with the notice provisions of the Standby Purchase Agreement.

(e) Assignment. The Investors shall not assign this Agreement or any of their rights hereunder without the Company’s prior written consent.

[signature pages follow]

3

IN WITNESS WHEREOF, the Investors and the Company have caused their respective signature pages to this Agreement to be duly executed as of the date first written above.

[Signature Page to Series A Preferred Stock Exchange Agreement]

IN WITNESS WHEREOF, the Investors and the Company have caused their respective signature pages to this Agreement to be duly executed as of the date first written above.

[Signature Page to Series A Preferred Stock Exchange Agreement]

EXHIBIT A

STOCK POWER

For Value Received,                      (“Transferor”) hereby sells, assigns and transfers unto The Providence Service Corporation, a Delaware corporation (the “Company”),                      (            ) shares of Series A Convertible Preferred Stock, par value $0.001 per share, of the Company, standing in the name of Transferor on the books of the Company and represented by Certificate No.      herewith, and does hereby irrevocably constitute and appoint                      or any officer of the Company attorney-in-fact to transfer said stock on the books of the Company with full power of substitution in the premises.

Dated:                  , 201